Edition:
United States

AngioDynamics Inc (ANGO.OQ)

ANGO.OQ on NASDAQ Stock Exchange Global Select Market

17.10USD
4:00pm EDT
Change (% chg)

$0.05 (+0.29%)
Prev Close
$17.05
Open
$16.90
Day's High
$17.17
Day's Low
$16.90
Volume
159,013
Avg. Vol
91,828
52-wk High
$18.18
52-wk Low
$14.81

ANGO.OQ

Chart for ANGO.OQ

About

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided... (more)

Overall

Beta: 1.11
Market Cap(Mil.): $623.70
Shares Outstanding(Mil.): 36.58
Dividend: --
Yield (%): --

Financials

  ANGO.OQ Industry Sector
P/E (TTM): 129.19 30.22 32.70
EPS (TTM): 0.13 -- --
ROI: 0.77 13.77 14.88
ROE: 0.98 16.61 16.12

BRIEF-AngioDynamics reports Q4 loss per share $0.30

* Reports FY 2017 GAAP EPS of $0.19; adjusted EPS of $0.73, up 22% compared to FY2016​

Jul 18 2017

BRIEF-AngioDynamics announces FDA clearance for Solero microwave tissue ablation system

* AngioDynamics announces FDA clearance for the solero microwave tissue ablation system

Jun 07 2017

BRIEF-AngioDynamics lawsuit claims C.R. Bard is violating antitrust laws, harming competition, limiting access

* AngioDynamics - "C.R. Bard has illegally tied sale of tip location systems to line of peripherally inserted central catheters," as per lawsuit filed by co

May 31 2017

BRIEF-Angiodynamics announces pricing of secondary offering by selling stockholders

* Angiodynamics announces pricing of secondary offering by selling stockholders

Apr 06 2017

BRIEF-Angiodynamics reports Q3 earnings per share $0.08

* Q3 earnings per share view $0.15 -- Thomson Reuters I/B/E/S

Mar 30 2017

BRIEF-Angiodynamics receives CE mark certification for the Solero Microwave Tissue Ablation System

* Angiodynamics receives CE mark certification for the Solero Microwave Tissue Ablation System Source text for Eikon: Further company coverage:

Mar 14 2017

Earnings vs. Estimates